BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15383186)

  • 21. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.
    Mathers MJ; Klotz T; Brandt AS; Roth S; Sommer F
    BJU Int; 2008 May; 101(9):1129-34. PubMed ID: 18190629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil.
    Dadkhah F; Safarinejad MR; Asgari MA; Hosseini SY; Lashay A; Amini E
    Int J Impot Res; 2010; 22(1):51-60. PubMed ID: 19865092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra) for erectile dysfunction.
    McCullough AR; Carson CC; Hatzichristou D
    Urology; 2006 Sep; 68(3 Suppl):38-46. PubMed ID: 17011374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.
    Shabsigh R; Kaufman JM; Steidle C; Padma-Nathan H
    J Urol; 2004 Aug; 172(2):658-63. PubMed ID: 15247755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study.
    Safarinejad MR; Taghva A; Shekarchi B; Safarinejad Sh
    Int J Impot Res; 2010; 22(5):325-35. PubMed ID: 20861846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors predicting successful response to sildenafil after radical cystoprostatectomy.
    El-Bahnasawy MS; Ismail T; Elsobky E; Alzalouey EI; Bazeed MA
    Scand J Urol Nephrol; 2008; 42(2):110-5. PubMed ID: 17853038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-esteem, confidence and relationship satisfaction of men with erectile dysfunction treated with sildenafil citrate: a multicenter, randomized, parallel group, double-blind, placebo controlled study in the United States.
    O'Leary MP; Althof SE; Cappelleri JC; Crowley A; Sherman N; Duttagupta S;
    J Urol; 2006 Mar; 175(3 Pt 1):1058-62. PubMed ID: 16469617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in Nigerian men.
    Osegbe DN; Shittu OB; Aghaji AE; Onyemelukwe GC; Dogo D; Dikko AA
    Int J Impot Res; 2003 Apr; 15 Suppl 1():S15-8. PubMed ID: 12825104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
    Eardley I; Wright P; MacDonagh R; Hole J; Edwards A
    BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea.
    Choi HK; Ahn TY; Kim JJ; Kim SC; Paick JS; Suh JK; Kim HS; Kim YK; Lee WH; Oh BH; Park CH; Ryu WS; Chung TG; Kim SW; Lee WH; Moon DG; Ryu DS; Seo KK; Kim DK; Lee DS
    Int J Impot Res; 2003 Apr; 15(2):80-6. PubMed ID: 12789384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age.
    Steidle CP; Stecher VJ; Pace C; Tseng LJ;
    Curr Med Res Opin; 2006 May; 22(5):939-48. PubMed ID: 16709315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa.
    Levinson IP; Khalaf IM; Shaeer KZ; Smart DO
    Int J Impot Res; 2003 Apr; 15 Suppl 1():S25-9. PubMed ID: 12825106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial.
    Heiman JR; Talley DR; Bailen JL; Oskin TA; Rosenberg SJ; Pace CR; Creanga DL; Bavendam T
    BJOG; 2007 Apr; 114(4):437-47. PubMed ID: 17284249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil versus the vacuum erection device: patient preference.
    Chen J; Mabjeesh NJ; Greenstein A
    J Urol; 2001 Nov; 166(5):1779-81. PubMed ID: 11586223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
    Morano S; Mandosi E; Fallarino M; Gatti A; Tiberti C; Sensi M; Gandini L; Buchetti B; Lenti L; Jannini EA; Lenzi A
    Eur Urol; 2007 Dec; 52(6):1768-74. PubMed ID: 17478034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.
    Burnett AL; Strong TD; Trock BJ; Jin L; Bivalacqua TJ; Musicki B
    J Urol; 2009 Jan; 181(1):245-51. PubMed ID: 19013603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of sildenafil in treating erectile dysfunction in PTSD patients: a double-blind, placebo-controlled crossover study.
    Orr G; Weiser M; Polliack M; Raviv G; Tadmor D; Grunhaus L
    J Clin Psychopharmacol; 2006 Aug; 26(4):426-30. PubMed ID: 16855464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.